Administration of FGF9 for treatment and prevention of major depression
US9957568B2 · kind B2 · utility
0Cited by
5References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 2016 |
| Grant date | May 1, 2018 |
| Priority date | — |
| Expiry date | Sep 20, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/304
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for diagnosing mental disorders. The invention also provides methods of identifying modulators of mental disorders as well as methods of using these modulators to treat patients suffering from mental disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.